Genmab A (GMAB) Current Assets (2018 - 2026)

Genmab A's Current Assets history runs 7 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• Quarterly Current Assets fell 36.26% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (down 36.26% YoY) and the FY2025 annual result came in at $2.9 billion, down 26.03% from the prior year.
• Current Assets was $2.6 billion for Q1 2026 at Genmab A, down from $2.9 billion in the prior quarter.
• Across five years, Current Assets topped out at $4.9 billion in Q4 2023 and bottomed at -$2.4 billion in Q3 2024.
• A 4-year average of $2.7 billion and a median of $3.9 billion in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2025 — Current Assets soared 1305.07% — and 2026, when it plunged 36.26%.
• Genmab A's Current Assets stood at $4.9 billion in 2023, then declined by 20.6% to $3.9 billion in 2024, then fell by 26.03% to $2.9 billion in 2025, then retreated by 10.81% to $2.6 billion in 2026.
• Business Quant data shows GMAB's Current Assets at $2.6 billion in Q1 2026, $2.9 billion in Q4 2025, and $4.5 billion in Q3 2025.